Burns & Levinson Represents Btr In $15 Million Series A Preferred Financing Raise
Mar 08, 2022•over 3 years ago
Amount Raised
$15 Million
Round Type
series a
Description
Burns & Levinson represented client BTR (Boston Technology Research Corporation), a regulatory technology company serving healthcare, life sciences and SaMD, in a $15 million Series A Preferred financing round led by New York-based global venture capital and private equity firm Insight Partners, with participation from existing investors LRV Health, NewStack Ventures and others. The new funding will be used to ensure that BTR's customers are prepared for the FDA's anticipated guidance that will incentivize a move from traditional methods to new technologies.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech